FDA MIN WARNS PATANJALI: NO FALSE CLAIMS

MUMBAI: State food and drug administration (FDA) minister Rajendra Shingne has warned Patanjali of strict action if it misled people saying its newly launched Coronil cures Covid-19. Shingne, in a press statement issued on Friday, said the medicine launched by Patanjali does not cure Covid-19, although the company was claiming so.

“The advertisements are misleading and spreading misconceptions among the people. The tablets launched by the company are, in fact, useful in boosting immunity as it contains ashwagandha, tulsi and giloy. Such tablets do not cure coronavirus. If the company continues to mislead through its advertisements, action would be initiated against it under Drugs and Magic Remedies (Objectionable Advertisements) Act,” he said.

SK Tijarawala, spokesperson, Patanajli Ayurveda, said, “We have neither been making any advertising or propaganda. We have launched our product with due permissions and registration from the government authorities concerned. Even Ayush ministry in its letter to us has praised us for the Covid-19 management Patanjali has done with its drug.”